Parkinson

Neurology

Prevalence

150.0 / 100K

Incidence

15.0 / 100K/yr

101 drugs in development·58 companies·2 clinical trials

Drug Pipeline by Phase

Approved(17)

Drug	Company
APOKYN	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
azilect	Teva Pharmaceutical Industries Limited (TEVA)
crexont	Impax Laboratories, LLC (IPXL)
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
gocovri	Adamas Pharmaceuticals Inc (ADMS)
GOCOVRI	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
inbrija	Acorda Therapeutics, Inc. (ACOR)
IPX203	Amneal Pharmaceuticals, Inc. (AMRX)
IPX203 (CREXONT)	Amneal Pharmaceuticals, Inc. (AMRX)
ONAPGO	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
ONGENTYS	Amneal Pharmaceuticals, Inc. (AMRX)
osmolex er	Adamas Pharmaceuticals Inc (ADMS)
ropinirole	DR REDDYS LABORATORIES LTD (RDY)
ropinirole	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
RYTARY	Amneal Pharmaceuticals, Inc. (AMRX)
vyalev	AbbVie Inc. (ABBV)
XADAGO	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Phase 3(14)

Drug	Company
abbv-951	AbbVie Inc. (ABBV)
AL050	Alector, Inc. (ALEC)
ANAVEX®2-73	ANAVEX LIFE SCIENCES CORP. (AVXL)
ap-cd/ld	INTEC PHARMA LTD. (NTEC)
buntanetap	Annovis Bio, Inc. (ANVS)
buntanetap/posiphen	Annovis Bio, Inc. (ANVS)
Levodopa carbidopa intestinal gel	AbbVie Inc. (ABBV)
Levodopa-carbidopa intestinal gel	AbbVie Inc. (ABBV)
Prasinezumab	PROTHENA CORP PUBLIC LTD CO (PRTA)
risvodetinib	Inhibikase Therapeutics, Inc. (IKT)
Rivastigmine Transdermal System	UNITED THERAPEUTICS Corp (UTHR)
tavapadon	Cerevel Therapeutics Holdings, Inc. (CERE)
Telmisartan	UNITED THERAPEUTICS Corp (UTHR)
Terazosin	UNITED THERAPEUTICS Corp (UTHR)

Phase 2(24)

Drug	Company
Active drug	ACADIA PHARMACEUTICALS INC (ACAD)
ANAVEX® 2-73 (blarcamesine)	ANAVEX LIFE SCIENCES CORP. (AVXL)
ARV-102	ARVINAS, INC. (ARVN)
axo-lenti-pd	Sio Gene Therapies Inc. (SIOX)
biib122	Denali Therapeutics Inc. (DNLI)
BIIB122	BIOGEN INC. (BIIB)
energi-f705	IMPACT BIOMEDICAL INC. (IBO)
gt-02287	Gain Therapeutics, Inc. (GANX)
high dose gt-02287	Gain Therapeutics, Inc. (GANX)
ins-gsh	GH Research PLC (GHRS)
kds2010	SCILEX HOLDING CO (SCLX)
lenrispodun	Intra-Cellular Therapies, Inc. (ITCI)
lenrispodun (ITI-214)	Intra-Cellular Therapies, Inc. (ITCI)
low dose gt-02287	Gain Therapeutics, Inc. (GANX)
MLR-1019	Adhera Therapeutics, Inc. (ATRX)
NEU-411	Crinetics Pharmaceuticals, Inc. (CRNX)
nyx-458	Aptinyx Inc. (APTX)
Pimavanserin	ACADIA PHARMACEUTICALS INC (ACAD)
Quetiapine	ACADIA PHARMACEUTICALS INC (ACAD)
RO7046015	PROTHENA CORP PUBLIC LTD CO (PRTA)
Sodium Chloride	PROTHENA CORP PUBLIC LTD CO (PRTA)
Suvecaltamide	Jazz Pharmaceuticals plc (JAZZ)
Temsirolimus	ELI LILLY & Co (LLY)
ucb0599	GT Biopharma, Inc. (GTBP)

Phase 1(13)

Drug	Company
aln-snca	REGENERON PHARMACEUTICALS, INC. (REGN)
biib094	IONIS PHARMACEUTICALS INC (IONS)
isc-hpnsc	International Stem Cell CORP (ISCO)
Levodopa-Carbidopa	AbbVie Inc. (ABBV)
LP659	Longboard Pharmaceuticals, Inc. (LBPH)
LY3884961	ELI LILLY & Co (LLY)
ly3962681	Prevail Therapeutics Inc. (PRVL)
LY4006896	ELI LILLY & Co (LLY)
ov350	Ovid Therapeutics Inc. (OVID)
ser 214	Serina Therapeutics, Inc. (SER)
ser-252	Serina Therapeutics, Inc. (SER)
SER-252	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
ub-312	Vaxxinity, Inc. (VAXX)

Preclinical(17)

Drug	Company
aav-gad	MeiraGTx Holdings plc (MGTX)
ADP050-ABC	Alector, Inc. (ALEC)
ADP062-ABC	Alector, Inc. (ALEC)
aeol 11114b	AEOLUS PHARMACEUTICALS, INC. (AOLS)
aeol 11207	AEOLUS PHARMACEUTICALS, INC. (AOLS)
cb101	CANTABIO PHARMACEUTICALS INC. (CTBO)
cb102	CANTABIO PHARMACEUTICALS INC. (CTBO)
cb201	CANTABIO PHARMACEUTICALS INC. (CTBO)
cpt60621	COEPTIS THERAPEUTICS INC. (NDYN)
ergod2 neuro	ENTIA BIOSCIENCES, INC. (ERGO)
gba1 gene replacement	Voyager Therapeutics, Inc. (VYGR)
gba1 gene therapy	Voyager Therapeutics, Inc. (VYGR)
novel cannabinoid therapeutic	Greater Cannabis Company, Inc. (GCAN)
ropinirole tds	Corium International, Inc. (CORI)
ser 252	Serina Therapeutics, Inc. (SER)
sls-004	SEELOS THERAPEUTICS, INC. (SEEL)
sls-007	SEELOS THERAPEUTICS, INC. (SEEL)

Unknown(7)

Drug	Company
15-0 h20	GH Research PLC (GHRS)
15-0 h20	National Research Corporation Common Stock (Delaware) (NRC)
15-0 H20	Valneva SE (VALN)
al-101	Oncotelic Therapeutics, Inc. (OTLC)
CPT60621	Coeptis Therapeutics Holdings Inc. (COEP)
crexont	Amneal Pharmaceuticals, Inc. (AMRX)
GBA1 discovery program	Camp4 Therapeutics Corp (CAMP)

N/A(1)

Drug	Company
Tavapadon	AbbVie Inc. (ABBV)

Phase 1/Phase 2(3)

Drug	Company
gene therapy	Calidi Biotherapeutics Inc. (CLDI)
ly3884961	Prevail Therapeutics Inc. (PRVL)
pr001	Prevail Therapeutics Inc. (PRVL)

Phase 2/Phase 3(1)

Drug	Company
dalzanemdor	Sage Therapeutics, Inc. (SAGE)

Phase 4(4)

Drug	Company
crexont er	Impax Laboratories, LLC (IPXL)
Pimavanserin 34 milligrams [Nuplazid]	ACADIA PHARMACEUTICALS INC (ACAD)
Pimavanserin tartrate	ACADIA PHARMACEUTICALS INC (ACAD)
Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]	ACADIA PHARMACEUTICALS INC (ACAD)

BioSniper tracks 101 drugs in development for Parkinson across 58 companies.

There are 2 clinical trials targeting Parkinson tracked by BioSniper.

The estimated prevalence of Parkinson is approximately 150.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.